Dr. Blaha is a member of the Bayer AG Global Advisory Board ... modification and aggressive management of relevant risk factors, including the use of low-dose aspirin, may be recommended for ...

Bayer is pressing ... given alongside aspirin plus a P2Y12 inhibitor – at one year. Once again, there was no significant observed increase in bleeding with asundexian at any dose or compared ...

In addition, the COMPASS trial showed aspirin plus the vascular dose of rivaroxaban (2.5 mg twice daily; Xarelto, Janssen/Bayer ... at high ischemic risk and low bleeding risk, especially ...

(IN BRIEF) Recent studies suggest that current cardiovascular risk assessment methods may be inadequate and call for a more personalized approach. Tools like carotid ultrasound offer promising ...

Scientists found that aspirin blocks TXA2, freeing T cells to fight cancer. This discovery could help prevent metastasis, but ...

A new study has revealed how aspirin may help prevent cancer from spreading by boosting the body's immune response.

Scientists have discovered that aspirin may prevent cancer metastasis by reducing TXA2 levels, which suppress T cells.

Daily aspirin use after standard adjuvant therapy did not improve DFS for patients with colorectal cancer, according to ...

As low-dose prophylactic aspirin therapy becomes common among older people, potential risks that are associated with such treatment assume increasing importance. In particular, some clinicians are ...

Through a mouse study, scientists have found that aspirin may help prevent metastases, or secondary tumors, by boosting the ...

A new report shows that almost half of the adults in the US aren’t aware of the latest health guidelines around aspirin, which claim the risks of a daily low-dose aspirin outweigh the benefits ...

New 'Eureka moment' research suggests aspirin supports a boost in the immune system to help catch deadly cancer cells ...